Certified by Founder Lodge
Septerna
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $150,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Septerna is on a mission to make the promise of future GPCR medicines a reality for patients. Combining the latest advances in biochemical, structural and computational drug discovery approac
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 18 ,2023 | Series B | $150,000,000 |
Goldman Sachs Asset Management
Vertex Ventures HC
Casdin Capital, LLC
RA Capital Management, L.P.
Catalio Capital Management
Third Rock Ventures
Soleus Capital Management, L.P.
Logos Capital
Samsara BioCapital
Driehaus Capital Management LLC
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
